CRL vs RTX · rev $2.00B vs P/E 36, rev $46.78B
Charles River Laboratories (CRL) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
CRL currently screens at market cap $7.78B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the CRL and RTX stock pages for the full models.
Not investment advice.